Fresenius SE & Co. KGaA



 


WELCOME TO FRESENIUS SE

Fresenius - the health care group

Fresenius is a global health care group with products and services for dialysis, the hospital and the medical care of patients at home.

The Fresenius Group consists of the following four business segments that are responsible for their own business operations worldwide: Fresenius Medical Care, Fresenius KabiFresenius Helios and Fresenius Vamed.


Latest news

12.08.2014
Fresenius mourns death of Dr. Gerhard Rupprecht

Fresenius is mourning the loss of Dr. Gerhard Rupprecht, who died in an accident at the end of last week.

>>>
01.08.2014
Fresenius stock split becomes effective as scheduled – First trading day on August 4

The stock split with capital increase from company funds was recorded in the commercial register today. After close of trading, shareholder’s deposits and the stock exchange listing will be converted.

>>>
31.07.2014
Accelerated growth in Q2 – Fresenius raises FY 2014 sales outlook, fully confirms earnings outlook

Ulf Mark Schneider, CEO of Fresenius, said: “All business segments showed marked improvement from the first quarter. The integration of the newly acquired hospitals is fully on track and we are pleased with their strong financial performance. (...)"

>>>
31.07.2014
Fresenius Medical Care reports strong operating results for the second quarter 2014 and confirms guidance for full year 2014

Rice Powell, chief executive officer of Fresenius Medical Care stated: “The second quarter showed sequentially enhanced revenue growth and improved strong operating performance. (...)"

>>>
22.07.2014
Fresenius implements stock split — first trading day planned for August 4

The stock split with capital increase from company funds approved by the Annual General Meeting in May will become effective on August 1, 2014, subject to entry in the commercial register. After close of trading, shareholders’ deposits and the stock exchange listing will be converted.

>>>